I'm definitively a skeptic when it comes to cholesterol drugs. Half of all people who die of heart attack have good cholesterol values, and the research behind the massive marketing effort to sell these drugs to the masses is sometimes fishy.
And now this in today's New York Times, who quotes the New England Journal of Medicine:
Journal Issues Warning on Two Cholesterol Drugs
"By ALEX BERENSON
Published: March 30, 2008
CHICAGO — Two widely prescribed cholesterol-lowering drugs, Vytorin and Zetia, may not work and should be used only as a last resort, The New England Journal of Medicine said in an editorial published on Sunday.
The journal’s conclusion came as doctors at a major cardiology conference in Chicago saw for the first time the full results of a two-year clinical trial that showed that the drugs failed to slow, and might have even sped up, the growth of fatty plaques in the arteries. Growth of those plaques is closely correlated with heart attacks and strokes."
5 weeks ago
No comments:
Post a Comment